NPI: 1013321033 · TAYLOR, MI 48180 · Urgent Care Clinic/Center · NPI assigned 06/18/2014
Authorized official MOLNAR, NANCY controls 20+ related entities in our dataset. Read more
| Authorized Official | MOLNAR, NANCY (MANAGER) |
| NPI Enumeration Date | 06/18/2014 |
Other providers sharing the same authorized official: MOLNAR, NANCY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,742 | $377K |
| 2019 | 10,983 | $508K |
| 2020 | 8,883 | $416K |
| 2021 | 15,654 | $670K |
| 2022 | 12,910 | $502K |
| 2023 | 16,428 | $586K |
| 2024 | 12,595 | $469K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21,703 | 20,134 | $1.17M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15,443 | 14,506 | $1.05M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6,993 | 6,932 | $450K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4,819 | 4,736 | $425K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6,406 | 5,698 | $165K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,700 | 1,893 | $48K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,800 | 3,685 | $46K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,135 | 1,040 | $36K |
| 99058 | 422 | 383 | $27K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,581 | 2,472 | $23K |
| 99000 | 10,559 | 9,781 | $23K | |
| 87428 | 1,130 | 1,077 | $23K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 357 | 352 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 271 | 269 | $9K |
| 81002 | 2,948 | 2,841 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 86 | 85 | $6K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 626 | 602 | $3K |
| 81025 | 468 | 459 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 627 | 623 | $2K |
| 87210 | 546 | 536 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,239 | 1,185 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 20 | 19 | $161.60 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 28 | 28 | $146.70 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 43 | 43 | $142.07 |
| 87807 | 13 | 13 | $97.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 54 | 53 | $38.59 |
| 99051 | 178 | 175 | $17.38 |